Bio-Rad adds new ddPCR assays, reagents and technologies for QX700 systems, expanding multiplex cancer mutation and biomarker ...
A study links early donor-derived cell-free DNA patterns to kidney transplant outcomes, including rejection and graft loss.
A study found Lucid’s nonendoscopic EsoCheck device achieved a 95% sample collection rate for esophageal precancer testing in ...
FDA clears Cepheid’s Xpert Hemorrhagic Fever Panel, a multiplex PCR test for Ebola, Marburg, Lassa, and Crimean-Congo viruses ...
FDA clears Roche cobas eplex RP3 panel, which detects up to 19 respiratory pathogen and adds Bordetella pertussis.
FDA clears Beckman Coulter's Access MeMed BV assay to help clinicians distinguish bacterial from viral infections on existing ...
A Mayo Clinic study of nearly 50,000 adults found many carriers of sickle cell and beta-thalassemia traits were not identified in electronic health records, highlighting gaps in current documentation ...
The FDA has cleared Contrario Medical’s Cyperus device for fertility labs to prepare motile sperm from semen using a ...
A clinical trial found that twice-per-pregnancy STI screening reduced preterm birth risk by 23% versus standard care.
Researchers developed a blood test using 10 biomarkers to help predict chronic disease risk and functional decline in adults.
Medicover Genetics introduces OncoSentia MRD, a plasma-based test for monitoring minimal residual disease in unresectable ...
Twist Bioscience launches Twist MRD Express, offering custom molecular residual disease panels with turnaround times starting ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results